Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2007
05/10/2007WO2007053498A1 Compounds useful as antagonists of ccr2
05/10/2007WO2007053495A2 Compounds useful as antagonists of ccr2
05/10/2007WO2007053394A1 Kinase inhibitors
05/10/2007WO2007053131A2 Acrylamide derivatives as antibiotic agents
05/10/2007WO2007053082A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma
05/10/2007WO2007052943A1 Novel antifungal triazole derivatives
05/10/2007WO2007052843A1 Heterocyclic amide compound and use thereof
05/10/2007WO2007052615A1 Pyridine derivative substituted by heterocycle and fungicide containing the same
05/10/2007WO2007051982A1 Triazole compounds as lipoxygenase inhibitors
05/10/2007WO2007051981A1 Pyrazoles useful in the treatment of inflammation
05/10/2007WO2007051619A1 N- (hetero) aryl indole derivatives as pesticides
05/10/2007WO2007025709A3 Organic compounds
05/10/2007WO2007015017A3 Novel polyquinoline derivatives and the therapeutic use thereof
05/10/2007WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
05/10/2007WO2006127205A3 Methods of preparing 3-cyano-quinolines and intermediates made thereby
05/10/2007WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
05/10/2007WO2006105081A3 Pharmacokinetically improved compounds
05/10/2007WO2006063113A3 Ureas as factor xa inhibitors
05/10/2007WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
05/10/2007WO2002010431A3 Functional biopolymer modification reagents and uses thereof
05/10/2007US20070105932 2H-or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/10/2007US20070105926 Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient
05/10/2007US20070105903 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
05/10/2007US20070105901 Novel piperidine derivative
05/10/2007US20070105899 Benzene compounds
05/10/2007US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease.
05/10/2007US20070105881 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives
05/10/2007US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives
05/10/2007US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors
05/10/2007US20070105858 Retinoic acid mimetic anilides
05/10/2007US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/10/2007US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/10/2007US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
05/10/2007US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring
05/10/2007US20070105839 2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
05/10/2007US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases
05/10/2007US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
05/10/2007US20070103060 Platinum complex and light emitting device
05/10/2007CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase
05/10/2007CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
05/10/2007CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase
05/10/2007CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase
05/10/2007CA2627673A1 Kinase inhibitors
05/10/2007CA2627516A1 Triazole compounds as lipoxygenase inhibitors
05/10/2007CA2626300A1 N-(hetero) aryl indole derivatives as pesticides
05/09/2007EP1783126A2 N-oxides of N-phenyl-2-pyrimidine-amine derivatives
05/09/2007EP1783125A1 Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
05/09/2007EP1783116A1 2-phenylpyridine derivative
05/09/2007EP1783114A1 N-(hetero)aryl indole derivatives as pesticides
05/09/2007EP1781650A1 Novel compounds having an anti-bacterial activity
05/09/2007EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors
05/09/2007EP1781639A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
05/09/2007EP1781638A2 Imidazolo-related compounds, compositions and methods for their use
05/09/2007EP1781637A1 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade
05/09/2007EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use
05/09/2007EP1781635A2 Potassium channel inhibitors
05/09/2007EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors
05/09/2007EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
05/09/2007EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs
05/09/2007EP1781619A1 Sigma receptor inhibitors
05/09/2007EP1781618A1 Sigma receptor inhibitors
05/09/2007EP1781617A2 Alpha, beta-unsaturated esters and acids by stereoselective dehydration
05/09/2007EP1781613A1 Piperidine derivatives as histamine h3 receptor ligands
05/09/2007EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists
05/09/2007EP1781293A1 Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
05/09/2007EP1680418B1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
05/09/2007EP1654229B1 Piperidine derivatives as ccr5 receptor modulators
05/09/2007EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders
05/09/2007EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors
05/09/2007EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment
05/09/2007EP1272477B1 Pyrimidine compounds
05/09/2007EP1238970B9 Cycloamine ccr5 receptor antagonists
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007EP1183245B1 Selective npy (y5) antagonists
05/09/2007CN1960990A Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
05/09/2007CN1960988A Compounds and compositions as protein kinase inhibitors
05/09/2007CN1960987A Process for the preparation of pyridin-2-ylmethylsulphinyl-1H-benzimidazol compounds
05/09/2007CN1960986A Butyrylcholinesterase selective inhibitors
05/09/2007CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
05/09/2007CN1960984A Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists
05/09/2007CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd
05/09/2007CN1960977A Quinazoline derivative
05/09/2007CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
05/09/2007CN1960971A Substituted pyrrolidine-2-ones
05/09/2007CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists
05/09/2007CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof
05/09/2007CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands
05/09/2007CN1958572A Compound in category of dihydro quinolines, preparation method, and composition of medication
05/09/2007CN1314739C Composition stabilized against thermal, oxidative or light-induced degradation and its preparing process
05/09/2007CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase
05/09/2007CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
05/09/2007CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity
05/09/2007CN1314669C 2,7-substituted indoles and their use as 5-HT6 modulators
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/08/2007US7214802 Anti-cytokine heterocyclic compounds
05/08/2007US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
05/08/2007US7214799 Protecting the hydroxyls of 3-hydroxy-4,5-dimethylol-2-picoline, reacting the 4-methylol group with an imide (especially potasssium phthalimide), cleaving the imide group to deprotect the amine group, and deprotecting the remaining hydroxy groups
05/08/2007US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids